Advertisement

Topics

Hepatitis B Foundation Company Profile

21:31 EDT 20th March 2019 | BioPortfolio

The Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure and improving the quality of life for those affected with hepatitis B worldwide through research, education and patient advocacy. Visit www.hepb.org.


News Articles [895 Associated News Articles listed on BioPortfolio]

Hepatitis C | Medscape

Review clinical reference information, guidelines, and medical news on hepatitis C--hepatitis C symptoms and hepatitis C treatment. Read about hepatitis C transmission, hepatitis C tests, hepatitis C ...

Effectiveness of chronic hepatitis C treatment using direct-acting antivirals: real-life data

Hepatitis is an inflammation of the liver and can be caused by medications, toxins, severe alcohol use and other medical conditions. Hepatitis can also be caused by viruses, most commonly hepatitis A,...

Hepatitis B | Medscape

Review in-depth clinical information, latest medical news, and guidelines on hepatitis B infection. Read the latest on prevention of hepatitis B virus with the hepatitis B vaccine.

Medical News Today: What to know about hepatitis E

Hepatitis E is a viral infection that causes liver damage and inflammation. Its symptoms can include fever, nausea, and fatigue. Treatment tends to involve rest and making some dietary changes. Learn ...

Medical News Today: Is there a vaccine for hepatitis C?

While vaccines exist for hepatitis A and B, researchers are still developing a vaccine for hepatitis C. Learn more about future treatments in this article.

Medical News Today: Benefits of the hepatitis B vaccine for newborns

Newborns receive the hepatitis B vaccine to prevent them from contracting the hepatitis B virus during their lifetime. Learn more about the benefits of the hepatitis B vaccine here.

Medical News Today: What are the best hepatitis C drugs?

Hepatitis C medications include Epclusa, Daklinsa, and Mavyret. The most effective medications may vary depending on the type of hepatitis C virus a person has. Learn more here.

Improving Hepatitis C DAA Access and Uptake

How does treatment with DAAs alter the social and individual experience of living with hepatitis C? This commentary highlights the need for an individual focus for outcome measures. Journal of Viral...

Drugs and Medications [32 Associated Drugs and Medications listed on BioPortfolio]

No7 protect and perfect foundation sunscreen broad spectrum spf 15 calico [boots retail usa inc]

NA

Meloxicam [kaiser foundation hospitals]

These highlights do not include all the information needed to use MELOXICAM TABLETS USP. safely and effectively. See full prescribing information for MELOXICAM TABLETS USP. MELOXICAM Tablets USP, for ...

Benzonatate [kaiser foundation hospitals]

Benzonatate Capsules, USP 100 mg

Misoprostol [kaiser foundation hospitals]

Misoprostol Tablets 8204001/0613 Rx Only

Oxygen [cornerstone mecial services - midwest, llc]

Oxygen

PubMed Articles [1143 Associated PubMed Articles listed on BioPortfolio]

Introduction of universal infant hepatitis B immunisation in the UK- paving the way to elimination.

In May 2016, the World Health Assembly ratified the first ever Global Health Sector Strategy (GHSS) on Viral Hepatitis to eliminate viral hepatitis as a public health threat by 2030. In pursuit of thi...

Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care.

Hepatitis C has increasingly affected women of child-bearing age over the past few years as a result of the opioid epidemic. In this review, we discuss the effect of hepatitis C on pregnancy outcomes,...

Pretreatment Hepatitis B Viral Load Predicts Long-term Hepatitis B Response after Anti-hepatitis C Therapy in Hepatitis B/C Dual-infected Patients.

We aimed to investigate the long-term outcomes in hepatitis B (HBV)/hepatitis C (HCV) dual-infected patients after anti-HCV therapy.

Hepatitis E Virus Genotype 1 and Hepatitis A Virus Dual Infection in Pediatric Patients with a Low Socioeconomic Status from Mexico.

We aimed to detect and characterize hepatitis E virus (HEV) RNA in sera samples from a pediatric population infected with the hepatitis A virus (HAV) exhibiting acute hepatitis and to correlate the in...

Comparison of ARIMA and GM(1,1) models for prediction of hepatitis B in China.

Hepatitis B virus (HBV) infection is a major public health threat in China for China has a hepatitis B prevalence of more than one million people in 2017 year. Disease incidence prediction may help he...

Clinical Trials [2289 Associated Clinical Trials listed on BioPortfolio]

Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients

Does vaccinating hemodialysis patients with Twinrix® (combination vaccine against hepatitis A and hepatitis B) result in a difference in hepatitis B antibody response in comparison to the...

Investigation of Hepatitis B and Hepatitis C in Taiwan

The purpose of this study is to investigate the differences of genotypes of hepatitis B and hepatitis C in Taiwan.

Management of Hepatitis C in HIV-Infected and Uninfected IDUs

The purpose of this study is to determine if hepatitis C has damaged the liver, whether each subject's hepatitis C is treatable with currently available medicines, whether patient educatio...

Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients

Individuals with resolved hepatitis B, characterized as hepatitis B surface antigen (HBsAg)-negative and hepatitis B core antibody-positive, have latent hepatitis B virus (HBV) infection i...

A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.

The purpose of this study is to determine if a hepatitis E vaccine is safe and able to prevent symptomatic liver disease due to the hepatitis E virus.

Companies [1519 Associated Companies listed on BioPortfolio]

Hepatitis B Foundation

The Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure and improving the quality of life for those affected with hepatitis B worldwide through resear...

World Hepatitis Alliance

The following people have provided quotes expressing their support to the World Hepatitis Alliance campaign for a WHO resolution on viral hepatitis. For further information please contact worldhep...

iQur Ltd

iQur® is a specialty pharmaceutical company at the forefront of international breakthroughs in the detection, treatment and monitoring of Hepatitis C and other liver diseases.iQur exists to provide c...

Eiger BioPharmaceuticals, Inc.

Eiger is focused on the discovery and development of new antiviral agents against novel targets for the treatment of hepatitis virus infections. Eiger's pipeline includes repurposed clinical stage the...

SciClone Pharmaceuticals

SciClone is a global biopharmaceutical company that acquires, develops, and commercializes specialist-oriented drugs for treating chronic and life-threatening diseases, such as hepatitis B, hepatitis ...

More Information about "Hepatitis B Foundation" on BioPortfolio

We have published hundreds of Hepatitis B Foundation news stories on BioPortfolio along with dozens of Hepatitis B Foundation Clinical Trials and PubMed Articles about Hepatitis B Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hepatitis B Foundation Companies in our database. You can also find out about relevant Hepatitis B Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...


Corporate Database Quicklinks



Searches Linking to this Company Record